07:30 - 08:45

Oral Posters - Neoplasia

Chairs: Pavle Košorok (Slovenia), Alexey Moskalev (Russia)

  • OP19: Is the preoperative chemoradiotherapy still a preferred option in current clinical settings? A frequency matching comparison study - Byung Kwan Park (Republic of Korea)
  • OP20: Optimal time interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients: a population based study - Anouk Rombouts (Netherlands)
  • OP21: Increased risk of colorectal cancer after oophorectomy in Sweden 1965-2011 - Josefin Segelman (Sweden)
  • OP22: Long-term outcomes of laparoscopic surgery for colon cancer in a national cohort - Kjartan Stormark (Norway)
  • OP23: Risk factors for anastomotic dehiscence after colon cancer surgery - Bodil Gessler (Sweden)
  • OP24: Does the location of mesorectal disruption have an impact on oncological outcome? - Emre Sivrikoz (Turkey)
  • OP25: Analysis of anastomotic leak in splenic flexure colon cancer. Results of the national prospective Spanish trial ANACO - Beatriz Arencibia (Spain)
  • OP26: Risk factors for anastomotic leak and morbimortality after oncologic left colon resection - Pablo Granero (Spain)
  • OP27: Robotic total mesorectal excision for low and ultralow rectal cancer: short-term postoperative outcomes and mid-term survival - Giampaolo Formisano (Italy)
  • OP28: Defining the optimal perioperative strategy for colorectal cancer resection: a network meta-analysis of 11,516 patient  - Andrew Currie (United Kingdom)
  • OP29: Postoperative complications after Hartmann's procedure in rectal cancer: a report from the Swedish colorectal cancer registry (SCRCR) - Ingvar Sverrisson (Sweden)
  • OP30: Laparoscopic wide mesocolic excision and central vascular ligation for carcinoma of the colon - Anu Ehrlich (Finland)
  • OP31: Should protective ileostomies be avoided at the time of proctocolectomy in FAP patients whenever reasonably safe? - Ralph Schneider (Germany)
  • OP32: Non-operative management of rectal cancer: too much hype? - Sunil Narang (UK)
  • OP33: Results of laparoscopic right colectomies, performed by multi- and single-port approaches for cancer: prospective randomized trial - Alexander Zapolskiy (Russia)

Oral Posters - Miscellaneous and Neoplasia

Chairs: Dragomir Dardanov (Bulgaria), Marek Szczepkowski (Poland)

  • OP34: Ischemic colitis: predictive factors of worse prognosis - Vincenzo Vigorita (Spain)
  • OP35: A comparison of results within and parallel to the randomised Ladies trial comparing sigmoidectomy with laparoscopic lavage for the treatment of purulent perforated diverticulitis; does randomisation influence outcomes? - Sandra Vennix (Netherlands)
  • OP36: Prognostic factors of postoperative mortality after surgical treatment for ischemic colitis - Lucinda Pérez Domínguez (Spain)
  • OP37: Damage control strategy in patients with acute perforated diverticular disease of sigmoid colon - Maximilian Sohn (Germany)
  • OP38: Impact of surgical site infection reduction strategy in colorectal resections - Simona Giuratrabocchetta (USA)
  • OP39: Ileo-anal pouch anastomosis: evolution of practice and post-operative outcomes: monocentric series of 348 patients over a 11 years period - Thevy Hor (France)
  • OP40: Should the superior rectal artery be preserved in laparoscopic sigmoid resection for diverticular disease? - Maximilian Sohn (Germany)
  • OP41: A randomised controlled trial on the use of Coca-Cola Zero® versus water for polyethylene glycol bowel preparation before colonoscopy - Isaac Seow-En (Singapore)
  • OP42: Thirty day mortality for elderly patients having elective colorectal surgery in highly developed countries - Alexander Engel (Australia)
  • OP43: Acute laparoscopic and open sigmoidectomy for perforated diverticulitis; a propensity score-matched cohort - Sandra Vennix (Netherlands)
  • OP44: Prophylactic negative pressure wound therapy in patients undergoing complex abdominal wall repair - Fleur de Vries (Netherlands)
  • OP45: Sacral nerve stimulation enhances intestinal epithelial barrier repair in a pig model of TNBS-induced rectal lesion - Jérémy Brégeon (France)
  • OP46: Inter-observer agreement of radiologists assessing the response of rectal cancers after chemoradiation therapy according to MRI tumour regression grading (mrTRG) - Muhammed Siddiqui (UK)
  • OP47: Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision - Nikolaos Gouvas (Greece)
  • OP48: Laparoscopic total mesorectal excision and delayed coloanal anastomosis without stoma for low rectal cancer. Experience learnt from 100 consecutive patients - Jean-Luc Faucheron (France)
The Liffey B

07:30 - 10:15

Educational: Trainees Video Session

Standardized step-by-step teaching videos

Chairs: Mike Parker (UK), Baljit Singh (UK)

Ethicon: part of the Johnson & Johnson family of companiesSupported by an educational grant from Ethicon

 The Liffey A

08:45 - 10:15

New Trials Forum

Presentation and review of new trials in the ESCP

Chairs: Dion Morton (UK)

  • New trials presentations: three proposals reviewed by an Expert panel:
    • T01: Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC Dutch randomized multicentre trial - Charlotte Klaver (Netherlands)
    • T02: Less Sto.Re.S trial multicentre randomised controlled trial of trans-anal reinforcement of low rectal anastomosis versus protective ileostomy in the prevention of anastomotic leak after rectal cancer - Donato Altomare (Italy)
    • T03: Hughes Abdominal Repair Trial (HART) - Rhiannon Harries (United Kingdom)
  • Guidelines synthesis: Evidence-based guideline recommendations on cytoreductive surgery and HIPEC for peritoneal carcinomatosis of colorectal cancer origin - Pieter Tanis (The Netherlands)
  • Launch of the ESCP cohort study for 2016

Trials posters T04-T11 will be presented alongside this session, on the level 3 foyer.

08:45 - 09:45 Ethicon: part of the Johnson & Johnson family of companiesEthicon Satellite Symposium: Risks and complications in colorectal surgery - impacts on patient outcomes  The Liffey B
10:15 - 10:45

RCSIThe Abraham Colles Keynote Lecture: Hirschsprung's disease and variants

Chair: Ronan O'Connell (Ireland)

Speaker: Prem Puri (Ireland)

Awarded by Royal College of Surgeons of Ireland

10:45 - 11:45 Long Coffee Break  Exhibition Hall
Medtronic: Further, TogetherMedtronic Satellite Symposium: Sacral neuromodulation therapy - advancements in clinical research  The Liffey B
Storz: Karl Storz - EndoskopeKarl Storz Small Hall Session: VAAFT – Video assisted anal fistula treatment (10:45 - 11:10)  Exhibition Hall
Medtronic: Further, TogetherMedtronic Small Hall Session: Biological mesh in Complex abdominal Wall Repair: What is Crosslinking and what is the evidence? (11:20-11:45)

10:45 - 12:45

Educational: Trainee Round Table Session

Case presentations and table discussion with Experts

Chair: Pierpaolo Sileri (Italy)

Experts: Donato Altomare (Italy), Ethem Gecim (Turkey), Dieter Hahnloser (Switzerland), Zoran Krivokapic (Serbia), Guillaume Meurette (France), Gabriella Möslein (Germany), Tom Øresland (Norway), Yves Panis (France), Carolynne Vaizey (United Kingdom), Evaghelos Xynox, (Greece), David Zimmerman (Netherlands)

Case presentations:

 The Liffey A

11:45 - 13:15

The Six Best and Visiting Fellow Free Papers

Chairs: Stefan Post (Germany), Yury Shelygin (Russia)bjs-logo

The Six Best Papers:

  • B1: Laparoscopic lavage versus primary resection for acute perforated diverticulitis (SCANDIV): a Scandinavian randomised trial - Johannes K. Schultz (Norway)
  • B2: Paradoxial impact of ileo-pouch-anal-anastomosis on male and female fertility - Frederik Rønne Pachler (Denmark)
  • B3: Organ-preservation for clinical complete responders after chemoradiation for rectal cancer: does timing of selection matter? - Milou Martens (Netherlands)
  • B4: The risk of secondary tumours in patients treated with radiotherapy for rectal cancer - Anna Martling (Sweden)
  • B5: Correlation between MRI detected extra-mural vascular invasion in rectal cancer and metastatic disease: a meta-analysis - Muhammed Siddiqui (UK)
  • B6: Identification of internal and external sphincter progenitor cells as potential tools for tailored cell therapy in faecal incontinence: the first study using the human anal sphincter - Son Il Tae (Republic of Korea)

International Visiting Fellow Free Papers:

  • ASCRS Visiting Fellow: Surgical site infection following colorectal surgery: in the eye of the beholder? - Traci Hedrick
  • Korean Visiting Fellow: Factors associated with adequate lymph node harvest in colorectal cancer: the clinical impact of the National Quality Assessment Program and Big Data management - In Kyu Lee
  • Japanese Visiting Fellow: Randomised controlled trial of high ligation or low ligation in anterior resection of rectal cancer - Kenji Matsuda


13:15 - 14:30 Long Lunch/Exhibition/Posters/Lunchtime Posters Exhibition Hall
Fisher & Paykel HealthcareFisher & Paykel Healthcare Small Hall Session: Prevention of hypothermia and inflammation improves cancer and long term survival outcomes (13:30 - 13:55)
EdwardsEdwards Lifescience Small Hall Session: Do not underestimate the power of fluids nor of team work (14:05 - 14:30)
Frankenman International LimitedFrankenman Satellite Symposium: The evolution of trans-anal minimally invasive surgery - from reduced port to TAMIS (13:30 - 14:30)  The Liffey B

Educational: Workshop for Authors: How to write a paper

A Colorectal Disease teaching sessionwiley

Chairs: Anna Martling (Sweden)

 The Liffey A

14:30 - 15:30

Symposium: Palliative surgical care

Chairs: Hartwig Kørner (Norway), Søren Laurberg (Denmark)

  • Palliative surgical care: content, credibility and challenges in daily practice - Geoffrey Dunn (USA)
  • Palliative surgery in colorectal cancer – what is the evidence? - Helgi Kjartan Sigurdsson (Iceland)
  • Research in palliative care – what can surgeons learn? - Stein Kaasa (Norway)

15:30 - 16:00

Keynote Lecture: Is robotic surgery hype, or the next best thing in colorectal surgery?

Chair: Mike Parker (UK)

wileySpeaker: Andrea Coratti (Italy)

Supported by Colorectal Disease

16:00 - 16:25 Coffee Break Exhibition Hall
16:00 - 16:25 Fisher & Paykel HealthcareFisher & Paykel Healthcare Small Hall Session: Reducing the risks of tumour metastasis, SSI’s and their associated costs in laparoscopic surgery
Exhibition Hall
16:00 - 17:15

Educational: Interactive Trainee Workshop

Case presentations

Chair: Filippo La Torre (Italy)


 The Liffey A
16:25 - 16:40

Ethicon: part of the Johnson & Johnson family of companiesMedtronic: Further, TogetherESCP Fellowships Update II

Chair: Ronan O'Connell (Ireland)

2014-15 ESCP Fellowships are supported by educational partners

16:40 - 17:40

Free Papers - Proctology

Chairs: Goran Barisic (Serbia), Nir Wasserberg (Israel)

  • F25: Role of Magnetic Resonance Imaging (MRI) in fistula-in-ano. A MRI-operation correlation in 229 consecutive patients: can we decide the indications of getting MRI in fistula-in-ano patients? - Pankaj Garg (India)
  • F26: Optimising diagnosis of haemorrhoidal disease and mucosal prolapse in patients referred for surgery by comparing two settings of work up. A prospective and multicentre study - Corrado Asteria (Italy)
  • F27: Hemorrhoidal treatment: a national survey of surgeons - Robin van Tol (Netherlands)
  • F28: Video Assisted Anal Fistula Treatment (VAAFT) - Piercarlo Meinero (Italy)
  • F29: Sacral nerve stimulation for faecal incontinence: how long the test-phase should be? - Isabelle Etienney (France)
  • F30: Unhealed wounds after proctologic operations. What to do? - Alexandr Titov (Russia)
Liffey Hall 2

Free Papers - Neoplasia

Chairs: Dursun Bugra (Turkey), Karen Nugent (UK)

  • F31: What are the specificities of N1c colorectal cancer? A study of 1120 cancers operated on between 2011 and 2014 - Morgane Bouquot (France)
  • F32: Outcomes in 1000 patients with appendiceal tumours treated in a single specialised centre - Simon A Fallis (UK)
  • F33: Parastomal hernia prevention through laparoscopic modified Sugarbaker technique with composite mesh (Physiomesh™). A multicentre randomised controlled trial - Xavier Serra-Aracil (Spain)
  • F34: National survey about practice patterns in presence of complex situations for the management of rectal cancer. Opinions of more than 700 French specialists (surgeon, oncologist, radiologist). An inter-group study (AFC, AGEO, FCVD, FFCD, FRENCH, GERCOR, GRECCAR, SFCD, SFRO, SNFCP, SNFGE) - Jérémie Lefevre (France)
  • F35: Delay in re-intervention after false negative CT-scan for colorectal anastomotic leakage: a reason for concern - Carla Marres (Netherlands)
  • F36: Can raised inflammation-related blood markers following neoadjuvant chemoradiation predict complete pathological response in rectal cancer - Christina Fleming (Ireland)
Medtronic: Further, TogetherMedtronic Satellite Symposium: Improving patients' surgical and post-operative outcomes in colorectal procedures
 The Liffey B
17:40 - 18:10

ascrs-logoASCRS Keynote Lecture: Post-operative ileus: decreasing the risk

Chair: Yury Shelygin (Russia)

Speaker: Charles Littlejohn (USA)

18:10 - 18:45 ESCP Annual General Meeting Auditorium
20:00 ESCP Dinner at Trinity College, University of Dublin  
ESCP Affiliates